Childhood Cancer Incidence, New York State, 2015-2019
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI | Avg Annual Cases | Rate per 1,000,000 | 95% CI | |
| All Invasive Malignant Tumors | 285.8 | 247.2 | 152.8 | 135.8 | 213.6 | 189.5 | 346.4 | 287.9 | 652.2 | 189.9 | 183.4-196.5 | 998.6 | 214.5 | 208.6-220.6 |
| I Leukemias, myeloproliferative and myelodysplastic diseases | 88.8 | 76.8 | 42.2 | 37.5 | 42.2 | 37.4 | 52.6 | 43.7 | 173.2 | 50.2 | 46.9-53.6 | 225.8 | 48.5 | 45.7-51.5 |
| I(a) Lymphoid leukemias | 65.6 | 56.7 | 33.6 | 29.9 | 24.6 | 21.8 | 24.6 | 20.4 | 123.8 | 35.8 | 33.0-38.7 | 148.4 | 31.9 | 29.7-34.3 |
| I(b) Acute myeloid leukemia | 14.2 | 12.3 | 4.2 | 3.7 | 10.2 | 9.0 | 16.4 | 13.6 | 28.6 | 8.3 | 7.0-9.8 | 45.0 | 9.6 | 8.4-11.0 |
| II Lymphomas and reticuloendothelial neoplasms | 21.2 | 18.3 | 23.6 | 21.0 | 40.4 | 35.8 | 80.0 | 66.5 | 85.2 | 25.2 | 22.8-27.7 | 165.2 | 35.6 | 33.2-38.1 |
| II(a) Hodgkin lymphoma | 0.8 | 0.7 | 2.8 | 2.5 | 17.0 | 15.1 | 49.0 | 40.7 | 20.6 | 6.2 | 5.1-7.5 | 69.6 | 14.9 | 13.4-16.5 |
| II(b,c,d) Non-Hodgkin lymphomas | 20.2 | 17.5 | 20.8 | 18.5 | 23.2 | 20.6 | 30.4 | 25.3 | 64.2 | 18.9 | 16.9-21.0 | 94.6 | 20.5 | 18.7-22.4 |
| III CNS & misc intracranial & intraspinal neoplasms | 56.4 | 48.8 | 43.6 | 38.7 | 41.4 | 36.7 | 26.0 | 21.6 | 141.4 | 41.3 | 38.3-44.5 | 167.4 | 36.3 | 33.9-38.9 |
| III(a) Ependymomas and choroid plexus tumor | 6.0 | 5.2 | 2.8 | 2.5 | 2.4 | 2.1 | 2.4 | 2.0 | 11.2 | 3.2 | 2.4-4.2 | 13.6 | 2.9 | 2.3-3.7 |
| III(b) Astrocytoma | 28.4 | 24.6 | 24.4 | 21.7 | 23.0 | 20.4 | 13.6 | 11.3 | 75.8 | 22.2 | 20.0-24.5 | 89.4 | 19.4 | 17.7-21.3 |
| III(c) Intracranial and intraspinal embryonal tumors | 12.8 | 11.1 | 6.8 | 6.0 | 4.8 | 4.3 | 2.6 | 2.2 | 24.4 | 7.1 | 5.9-8.4 | 27.0 | 5.8 | 4.9-6.9 |
| III(d) Other gliomas | 7.0 | 6.1 | 8.6 | 7.6 | 10.0 | 8.9 | 6.0 | 5.0 | 25.6 | 7.6 | 6.3-9.0 | 31.6 | 6.9 | 5.9-8.1 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 39.0 | 33.7 | 6.6 | 5.9 | 1.0 | 0.9 | 1.6 | 1.3 | 46.6 | 13.1 | 11.5-14.9 | 48.2 | 10.2 | 8.9-11.5 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 39.0 | 33.7 | 6.6 | 5.9 | 0.8 | 0.7 | 1.0 | 0.8 | 46.4 | 13.1 | 11.4-14.9 | 47.4 | 10.0 | 8.8-11.3 |
| V Retinoblastoma | 15.8 | 13.7 | 0.4 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 16.4 | 4.6 | 3.6-5.7 | 16.6 | 3.5 | 2.8-4.3 |
| VI Renal tumors | 23.8 | 20.6 | 6.6 | 5.9 | 2.8 | 2.5 | 2.2 | 1.8 | 33.2 | 9.5 | 8.1-11.0 | 35.4 | 7.5 | 6.5-8.7 |
| VI(a) Nephroblastoma and other nonepithelial renal tumor | 23.8 | 20.6 | 6.2 | 5.5 | 1.0 | 0.9 | 0.0 | 0.0 | 31.0 | 8.8 | 7.5-10.3 | 31.0 | 6.6 | 5.6-7.7 |
| VII Hepatic tumors | 8.8 | 7.6 | 1.0 | 0.9 | 1.6 | 1.4 | 2.4 | 2.0 | 11.4 | 3.2 | 2.4-4.2 | 13.8 | 2.9 | 2.3-3.7 |
| VII(a) Hepatoblastoma and mesenchymal tumors of liver | 8.4 | 7.3 | 0.8 | 0.7 | 0.6 | 0.5 | 0.0 | 0.0 | 9.8 | 2.8 | 2.0-3.6 | 9.8 | 2.1 | 1.5-2.7 |
| VIII Malignant bone tumors | 2.2 | 1.9 | 7.4 | 6.6 | 21.8 | 19.3 | 23.4 | 19.4 | 31.4 | 9.4 | 8.0-11.0 | 54.8 | 11.9 | 10.6-13.4 |
| VIII(a) Osteosarcoma | 0.2 | 0.2 | 3.0 | 2.7 | 13.8 | 12.2 | 12.6 | 10.5 | 17.0 | 5.1 | 4.1-6.3 | 29.6 | 6.5 | 5.5-7.6 |
| VIII(c) Ewing tumor and related sarcomas of bone | 1.2 | 1.0 | 3.8 | 3.4 | 5.8 | 5.1 | 6.8 | 5.7 | 10.8 | 3.2 | 2.4-4.2 | 17.6 | 3.8 | 3.1-4.7 |
| IX Soft tissue and other extraosseous sarcomas | 16.2 | 14.0 | 10.8 | 9.6 | 17.2 | 15.3 | 23.2 | 19.3 | 44.2 | 12.9 | 11.3-14.8 | 67.4 | 14.5 | 13.0-16.2 |
| IX(a) Rhabdomyosarcoma | 10.6 | 9.2 | 4.8 | 4.3 | 4.8 | 4.3 | 6.4 | 5.3 | 20.2 | 5.8 | 4.8-7.1 | 26.6 | 5.7 | 4.8-6.8 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 7.8 | 6.7 | 4.4 | 3.9 | 10.0 | 8.9 | 34.6 | 28.8 | 22.2 | 6.5 | 5.3-7.8 | 56.8 | 12.1 | 10.7-13.6 |
| X(a) Intracranial and intraspinal germ cell tumor | 1.0 | 0.9 | 1.0 | 0.9 | 4.0 | 3.5 | 3.2 | 2.7 | 6.0 | 1.8 | 1.2-2.5 | 9.2 | 2.0 | 1.5-2.7 |
| X(c) Malignant gonadal germ cell tumor | 1.6 | 1.4 | 2.8 | 2.5 | 6.0 | 5.3 | 25.8 | 21.4 | 10.4 | 3.1 | 2.3-4.1 | 36.2 | 7.7 | 6.6-8.9 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 3.0 | 2.6 | 5.4 | 4.8 | 33.6 | 29.8 | 97.6 | 81.1 | 42.0 | 12.6 | 10.9-14.4 | 139.6 | 29.8 | 27.7-32.1 |
| XI(b) Thyroid carcinoma | 0.8 | 0.7 | 1.2 | 1.1 | 14.8 | 13.1 | 58.0 | 48.2 | 16.8 | 5.0 | 4.0-6.2 | 74.8 | 15.9 | 14.3-17.6 |
| XI(d) Malignant melanoma | 1.4 | 1.2 | 1.0 | 0.9 | 2.0 | 1.8 | 6.6 | 5.5 | 4.4 | 1.3 | 0.8-2.0 | 11.0 | 2.3 | 1.8-3.1 |
| XII Other and unspecified malignant neoplasms | 2.6 | 2.2 | 0.8 | 0.7 | 1.0 | 0.9 | 2.6 | 2.2 | 4.4 | 1.3 | 0.8-1.9 | 7.0 | 1.5 | 1.0-2.1 |
Notes
- Incidence data are provisional, November 2021.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
